Trial intelligence / Profile preview

Intravenous promethazine versus diazepam for peripheral vertigo in the emergency department

IRCT20171221037984N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in Peripheral vertigo comparing Intravenous promethazine with Intravenous diazepam (2 arms). Primary endpoint: Change in vertigo severity on visual analog scale. Started Mar 2015; status: completed.

02

Drugs

promethazinediazepam
03

Conditions

Peripheral vertigo

Beyond the preview

Go deeper on IRCT20171221037984N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171221037984N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call